Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · Real-Time Price · USD
33.69
-1.62 (-4.59%)
Feb 21, 2025, 4:00 PM EST - Market closed
Sanara MedTech Revenue
Sanara MedTech had revenue of $21.67M in the quarter ending September 30, 2024, with 35.24% growth. This brings the company's revenue in the last twelve months to $78.06M, up 24.66% year-over-year. In the year 2023, Sanara MedTech had annual revenue of $64.99M with 41.77% growth.
Revenue (ttm)
$78.06M
Revenue Growth
+24.66%
P/S Ratio
3.65
Revenue / Employee
$722,749
Employees
108
Market Cap
294.49M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 64.99M | 19.15M | 41.77% |
Dec 31, 2022 | 45.84M | 21.70M | 89.87% |
Dec 31, 2021 | 24.14M | 8.56M | 54.90% |
Dec 31, 2020 | 15.59M | 3.82M | 32.47% |
Dec 31, 2019 | 11.77M | 2.99M | 34.02% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
SMTI News
- 23 days ago - Sanara MedTech: A Promising Growth Story At An Attractive Valuation - Seeking Alpha
- 4 weeks ago - Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc. - GlobeNewsWire
- 4 weeks ago - Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd - GlobeNewsWire
- 4 weeks ago - Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments - GlobeNewsWire
- 4 weeks ago - Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024 - GlobeNewsWire
- 3 months ago - Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th - GlobeNewsWire
- 3 months ago - Sanara MedTech Inc. (SMTI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Sanara MedTech Inc. Reports Third Quarter 2024 Results - GlobeNewsWire